Boehringer Ingelheim International GmbH;Vitae Pharmaceuticals, Inc.
发明人:
CLAREMON, DAVID A.,ZHUANG, LINGHANG,LEFTHERIS, KATERINA,TICE, COLIN M.,XU, ZHENRONG,YE, YUANJIE,SINGH, SURESH B.,CACATIAN, SALVACION,ZHAO, WEI,HIMMELSBACH, FRANK
申请号：
PL09739203
公开号：
PL2300461T3
申请日:
2009.04.30
申请国别(地区):
PL
年份:
2013
代理人:
摘要：
Disclosed is a compound represented by Formula (Im1) or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof. Also disclosed are pharmaceutical compositions comprising the compound of Formula (Im1) or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof and methods of inhibiting 11&bgr；-HSD1 activity comprising the step of administering to a mammal in need of such treatment an effective amount of a compound of Formulas (Im1), or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof.
